Advertisement

Journal of Physiology and Biochemistry

, Volume 68, Issue 2, pp 263–269 | Cite as

Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats

Attenuation of diabetic nephropathy in rats
  • Ahmed Amir Radwan SayedEmail author
  • Mahmoud Khalifa
  • Fathy Fahim Abd el-Latif
Original Paper

Abstract

Diabetic nephropathy is a major cause of morbidity and mortality in diabetic patients. To prevent the development of this disease and to improve advanced kidney injury, effective therapies directed toward the key molecular target are required. In this paper, the efficacy of fenugreek to restore the kidney function of diabetic rats via its antioxidant and anti-inflammatory activities has been studied. Novel data showing the efficacy of fenugreek to attenuate progression of diabetic nephropathy and production of interleukin-6 (IL-6) in rats compared with a diabetic untreated group were obtained. Rats were classified into five groups; control, diabetic untreated, and three diabetic groups treated with fenugreek, rosiglitazone, and metformin. Treatment with fenugreek has been continued for 12 weeks. Fenugreek was found to significantly reduce the high levels of glucose, urea, creatinine, sodium, potassium, and IL-6 in serum compared with the diabetic untreated group. In addition, levels of malondialdehyde and IL-6 in the kidney homogenate were significantly reduced as a result of the fenugreek treatment compared with the diabetic untreated group. Moreover, concentration of GSH and the activity of both superoxide dismutase and catalase were considerably increased in the diabetic treated groups compared with the diabetic untreated group. Furthermore, glomerular mesangial expansion was reduced in the treated animal groups. These findings suggest a therapeutic potential of fenugreek against diabetic nephropathy, explain its antioxidative/anti-inflammatory properties and provide a direction for future research.

Keywords

Fenugreek Metformin Rosiglitazone Diabetic nephropathy 

Notes

Acknowledgements

The authors acknowledge the scientific guidance and continuous advice of Dr. Michael Morcos, Faculty of Medicine, Heidelberg University, Heidelberg, Germany. Deep thanks are for Dr. Wafaee Gomaa, Pathology Department, Faculty of Medicine, Minia University, El-Minia, Egypt, who did the histopathological examination of the kidneys.

References

  1. 1.
    Abdel-Bary JA, Abdel Hassan IA, Al-Hakiem MHH (1997) Hypoglycemic and antihyperglycemic effect of Trigonella foenum graecum leaf in normal and alloxan induced diabetic rats. J Ethnopharmacol 58:149–155CrossRefGoogle Scholar
  2. 2.
    Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126PubMedCrossRefGoogle Scholar
  3. 3.
    Al-Shamanty J, Shahba M, Al Khazraji Twaij HAA (1994) Hypoglycemic effect of Artemisia herb alba II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol 43:167–171CrossRefGoogle Scholar
  4. 4.
    Ankrah NA (1995) Alterations of glucose tolerance in mice fed low levels of aflatoxins and with depressed glyoxalase I activity. Vet Hum Toxicol 37:59–61PubMedGoogle Scholar
  5. 5.
    Ashokkumar N, Pari L (2005) Effect of N-benzoyl-d-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta 351:105–113PubMedCrossRefGoogle Scholar
  6. 6.
    Brouwers O, Niessen PM, Haenen G, Miyata T, Brownlee M, Stehouwer CD, De Mey JG, Schalkwijk CG (2010) Hyperglycemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 53:989–1000PubMedCrossRefGoogle Scholar
  7. 7.
    Choudhary D, Chandra D, Choudhary S, Kale RK (2001) Modulation of glyoxalase, glutathione S-transferase and antioxidant enzymes in the liver, spleen and erythrocytes of mice by dietary administration of fenugreek seeds. Food Chem Toxicol 39:989–997PubMedCrossRefGoogle Scholar
  8. 8.
    Ethan-Basch CU, Kuo G, Szapary P, Smith M (2003) Therapeutic applications of fenugreek. Altern Med Rev 8:20–27Google Scholar
  9. 9.
    Fukuzawa Y, Watanabe Y, Inaguma D, Hotta N (1996) Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state. J Lab Clin Med 128:568–578PubMedCrossRefGoogle Scholar
  10. 10.
    Hamden K, Masmoudi H, Carreau S, Elfeki A (2010) Immunomodulatory, β-cell, and neuroprotective actions of fenugreek oil from alloxan-induced diabetes. Immunopharmacol Immunotoxicol Immunopharmacol Immunotoxicol 32:437–445CrossRefGoogle Scholar
  11. 11.
    Hannan JMA, Ali L, Rokeya B, Khaleque J, Akhter M, Flatt PR, Abdel-Wahab YA (2007) Soluble dietary fiber fraction of Trigonella foenum graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr 97:514–521PubMedCrossRefGoogle Scholar
  12. 12.
    Haque N, Salma U, Nurunnabi TR, Uddin MJ, Jahangir MF, Islam SM, Kamruzzaman M (2011) Management of type 2 diabetes mellitus by lifestyle, diet and medicinal plants. Pak J Biol Sci 14:13–24PubMedCrossRefGoogle Scholar
  13. 13.
    Kanter M (2009) Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy. J Mol Hist 40:107–115CrossRefGoogle Scholar
  14. 14.
    Mao Z, Ye S, Zhai Z, Chen Y, Li X, Yang G, Fan A, Wang Y (2009) Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal monocyte chemoattractant protein-1 expression. J Diabetes Complications 23:124–129CrossRefGoogle Scholar
  15. 15.
    Morcos SR, Elhawary Z, Gabrial GN (1981) Protein rich food mixtures for feeding the young in Egypt. 1. Formulation. Z Ernährungswiss 20:275–282PubMedCrossRefGoogle Scholar
  16. 16.
    Morcos M, Sayed AAR, Bierhaus A, Yard B, Waldherr R, Merz W, Kloeting I, Schleicher E, Mentz S, el Baki RFAbd, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi KA, Schmidt A-M, Stern D, Ziegler R, Haering HU, Andrassy M, van der Woude F, Nawroth PP (2002) Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 51:3532–3544PubMedCrossRefGoogle Scholar
  17. 17.
    Morcos M, Schlotterer A, Sayed AAR, Kukudov G, Oikomonou D, Ibrahim Y, Pfisterer F, Schneider J, Bozorgmehr F, Rudofsky G Jr, Schwenger V, Kientsch-Engels R, Hamann A, Zeier M, Dugi K, Yard B, Humpert PM, van der Woude F, Nawroth PP, Bierhaus A (2008) Rosiglitazone reduces angiotensin ii and advanced glycation end product-dependent sustained nuclear factor-κB activation in cultured human proximal tubular epithelial cells. Horm Metab Res 40:752–759PubMedCrossRefGoogle Scholar
  18. 18.
    Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 67:582–589Google Scholar
  19. 19.
    Nishikimi M, Roa NA, Yogi K (1972) The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 46:849–854PubMedCrossRefGoogle Scholar
  20. 20.
    Okhawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissue by thiobarbituric acid. Anal Biochem 95:355–358Google Scholar
  21. 21.
    Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ (2001) Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 244:45–51CrossRefGoogle Scholar
  22. 22.
    Sauerheber RD, Kuhn CE, Hyslop PA (1984) Membrane structural/functional properties of adipocytes from normal and streptozotocin-diabetic rats. Diabetes 33:258–265PubMedCrossRefGoogle Scholar
  23. 23.
    Sayed AA (2008) Thymoquinone protects tubular epithelial cells against tubular injury. Cell Biochem Funct 26:374–380PubMedCrossRefGoogle Scholar
  24. 24.
    Sayed AA (2011) Ferulsinaic acid attenuation of AGEs extends life span of Caenorhabditis elegans. J Pharm Pharmacol 63:423–428PubMedCrossRefGoogle Scholar
  25. 25.
    Sayed AA (2012) Thymoquinone and proanthocyanidin attenuation of diabetic nephropathy in rats. Eur Rev Med Pharmacol Sci (in press)Google Scholar
  26. 26.
    Sayed AA, El-Shaieb K, Mourad A (2012) Life span extension of Caenorhabditis elegans by Novel pyrido perimidine drevative. Arch Pharmacal Res (in press)Google Scholar
  27. 27.
    Xue W, Lei J, Li X, Zhang R (2011) Trigonella foenum graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity. Nutr Res 31:555–562PubMedCrossRefGoogle Scholar
  28. 28.
    Xue W, Li X, Zhang J, Liu Y, Wang Z, Zhang R (2007) Effect of Trigonella foenum graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 16:422–426PubMedGoogle Scholar

Copyright information

© University of Navarra 2012

Authors and Affiliations

  • Ahmed Amir Radwan Sayed
    • 1
    • 2
    Email author
  • Mahmoud Khalifa
    • 2
  • Fathy Fahim Abd el-Latif
    • 2
  1. 1.Biochemistry Department, Faculty of ScienceKing Abdulaziz UniversityJeddahSaudi Arabia
  2. 2.Chemistry Department, Faculty of ScienceMinia UniversityEl-MiniaEgypt

Personalised recommendations